Rice Hall James & Associates’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.11M | Sell |
390,615
-18,247
| -4% | -$332K | 0.38% | 67 |
|
2025
Q1 | $8.11M | Sell |
408,862
-2,163
| -0.5% | -$42.9K | 0.48% | 53 |
|
2024
Q4 | $7.05M | Sell |
411,025
-7,011
| -2% | -$120K | 0.39% | 62 |
|
2024
Q3 | $8.36M | Sell |
418,036
-739,219
| -64% | -$14.8M | 0.45% | 59 |
|
2024
Q2 | $12.9M | Sell |
1,157,255
-49,244
| -4% | -$551K | 0.78% | 37 |
|
2024
Q1 | $7.96M | Buy |
+1,206,499
| New | +$7.96M | 0.45% | 57 |
|